A citation-based method for searching scientific literature


List of co-cited articles
635 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
William C Knowler, Elizabeth Barrett-Connor, Sarah E Fowler, Richard F Hamman, John M Lachin, Elizabeth A Walker, David M Nathan. N Engl J Med 2002
51

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
William C Knowler, Sarah E Fowler, Richard F Hamman, Costas A Christophi, Heather J Hoffman, Anne T Brenneman, Janet O Brown-Friday, Ronald Goldberg, Elizabeth Venditti, David M Nathan. Lancet 2009
29

Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.
Qiuhong Gong, Ping Zhang, Jinping Wang, Jixiang Ma, Yali An, Yanyan Chen, Bo Zhang, Xinxing Feng, Hui Li, Xiaoping Chen,[...]. Lancet Diabetes Endocrinol 2019
147
18

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto, J Lindström, J G Eriksson, T T Valle, H Hämäläinen, P Ilanne-Parikka, S Keinänen-Kiukaanniemi, M Laakso, A Louheranta, M Rastas,[...]. N Engl J Med 2001
15

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
X R Pan, G W Li, Y H Hu, J X Wang, W Y Yang, Z X An, Z X Hu, J Lin, J Z Xiao, H B Cao,[...]. Diabetes Care 1997
14


Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.
Jaana Lindström, Pirjo Ilanne-Parikka, Markku Peltonen, Sirkka Aunola, Johan G Eriksson, Katri Hemiö, Helena Hämäläinen, Pirjo Härkönen, Sirkka Keinänen-Kiukaanniemi, Mauri Laakso,[...]. Lancet 2006
14

The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.
Guangwei Li, Ping Zhang, Jinping Wang, Edward W Gregg, Wenying Yang, Qiuhong Gong, Hui Li, Hongliang Li, Yayun Jiang, Yali An,[...]. Lancet 2008
951
12


Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS).
J Lindström, M Peltonen, J G Eriksson, P Ilanne-Parikka, S Aunola, S Keinänen-Kiukaanniemi, M Uusitupa, J Tuomilehto. Diabetologia 2013
279
10

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
Carel W le Roux, Arne Astrup, Ken Fujioka, Frank Greenway, David C W Lau, Luc Van Gaal, Rafael Violante Ortiz, John P H Wilding, Trine V Skjøth, Linda Shapiro Manning,[...]. Lancet 2017
286
10


Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
10

Effect of weight loss with lifestyle intervention on risk of diabetes.
Richard F Hamman, Rena R Wing, Sharon L Edelstein, John M Lachin, George A Bray, Linda Delahanty, Mary Hoskin, Andrea M Kriska, Elizabeth J Mayer-Davis, Xavier Pi-Sunyer,[...]. Diabetes Care 2006
736
10

Impaired fasting glucose and impaired glucose tolerance: implications for care.
David M Nathan, Mayer B Davidson, Ralph A DeFronzo, Robert J Heine, Robert R Henry, Richard Pratley, Bernard Zinman. Diabetes Care 2007
850
9

Prediabetes: a high-risk state for diabetes development.
Adam G Tabák, Christian Herder, Wolfgang Rathmann, Eric J Brunner, Mika Kivimäki. Lancet 2012
9

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.
Rena R Wing, Paula Bolin, Frederick L Brancati, George A Bray, Jeanne M Clark, Mace Coday, Richard S Crow, Jeffrey M Curtis, Caitlin M Egan, Mark A Espeland,[...]. N Engl J Med 2013
9

Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.
Guangwei Li, Ping Zhang, Jinping Wang, Yali An, Qiuhong Gong, Edward W Gregg, Wenying Yang, Bo Zhang, Ying Shuai, Jing Hong,[...]. Lancet Diabetes Endocrinol 2014
367
9

Pioglitazone for diabetes prevention in impaired glucose tolerance.
Ralph A DeFronzo, Devjit Tripathy, Dawn C Schwenke, MaryAnn Banerji, George A Bray, Thomas A Buchanan, Stephen C Clement, Robert R Henry, Howard N Hodis, Abbas E Kitabchi,[...]. N Engl J Med 2011
471
8



Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
H C Gerstein, S Yusuf, J Bosch, J Pogue, P Sheridan, N Dinccag, M Hanefeld, B Hoogwerf, M Laakso, V Mohan,[...]. Lancet 2006
7

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.
Jean-Louis Chiasson, Robert G Josse, Ramon Gomis, Markolf Hanefeld, Avraham Karasik, Markku Laakso. Lancet 2002
7

Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.
Michael E J Lean, Wilma S Leslie, Alison C Barnes, Naomi Brosnahan, George Thom, Louise McCombie, Carl Peters, Sviatlana Zhyzhneuskaya, Ahmad Al-Mrabeh, Kieren G Hollingsworth,[...]. Lancet Diabetes Endocrinol 2019
233
7

Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release.
W Timothy Garvey, Donna H Ryan, Robert Henry, Nancy J V Bohannon, Hermann Toplak, Michael Schwiers, Barbara Troupin, Wesley W Day. Diabetes Care 2014
120
7


IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.
N H Cho, J E Shaw, S Karuranga, Y Huang, J D da Rocha Fernandes, A W Ohlrogge, B Malanda. Diabetes Res Clin Pract 2018
7

A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC's National Diabetes Prevention Program.
Elizabeth K Ely, Stephanie M Gruss, Elizabeth T Luman, Edward W Gregg, Mohammed K Ali, Kunthea Nhim, Deborah B Rolka, Ann L Albright. Diabetes Care 2017
165
7




Survey of primary care providers' knowledge of screening for, diagnosing and managing prediabetes.
Eva Tseng, Raquel C Greer, Paul O'Rourke, Hsin-Chieh Yeh, Maura M McGuire, Jeanne M Clark, Nisa M Maruthur. J Gen Intern Med 2017
35
14


The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity.
Jaana Lindström, Anne Louheranta, Marjo Mannelin, Merja Rastas, Virpi Salminen, Johan Eriksson, Matti Uusitupa, Jaakko Tuomilehto. Diabetes Care 2003
734
5

Vitamin D Supplementation and Prevention of Type 2 Diabetes.
Anastassios G Pittas, Bess Dawson-Hughes, Patricia Sheehan, James H Ware, William C Knowler, Vanita R Aroda, Irwin Brodsky, Lisa Ceglia, Chhavi Chadha, Ranee Chatterjee,[...]. N Engl J Med 2019
231
5

Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial.
Jordi Salas-Salvadó, Monica Bulló, Nancy Babio, Miguel Ángel Martínez-González, Núria Ibarrola-Jurado, Josep Basora, Ramon Estruch, Maria Isabel Covas, Dolores Corella, Fernando Arós,[...]. Diabetes Care 2011
462
5

Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.
Michael Ej Lean, Wilma S Leslie, Alison C Barnes, Naomi Brosnahan, George Thom, Louise McCombie, Carl Peters, Sviatlana Zhyzhneuskaya, Ahmad Al-Mrabeh, Kieren G Hollingsworth,[...]. Lancet 2018
626
5


Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014.
Mohammed K Ali, Kai McKeever Bullard, Sharon Saydah, Giuseppina Imperatore, Edward W Gregg. Lancet Diabetes Endocrinol 2018
88
5

The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
William H Herman, Thomas J Hoerger, Michael Brandle, Katherine Hicks, Stephen Sorensen, Ping Zhang, Richard F Hamman, Ronald T Ackermann, Michael M Engelgau, Robert E Ratner. Ann Intern Med 2005
458
5

Retention Among Participants in the National Diabetes Prevention Program Lifestyle Change Program, 2012-2017.
Michael J Cannon, Svetlana Masalovich, Boon Peng Ng, Robin E Soler, Rajai Jabrah, Elizabeth K Ely, Bryce D Smith. Diabetes Care 2020
25
20

Reach and Use of Diabetes Prevention Services in the United States, 2016-2017.
Mohammed K Ali, Kai McKeever Bullard, Giuseppina Imperatore, Stephen R Benoit, Deborah B Rolka, Ann L Albright, Edward W Gregg. JAMA Netw Open 2019
42
11

Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.
Hertzel C Gerstein, Pasqualina Santaguida, Parminder Raina, Katherine M Morrison, Cynthia Balion, Dereck Hunt, Hossein Yazdi, Lynda Booker. Diabetes Res Clin Pract 2007
340
5


Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS).
Leigh Perreault, Qing Pan, Emily B Schroeder, Rita R Kalyani, George A Bray, Samuel Dagogo-Jack, Neil H White, Ronald B Goldberg, Steven E Kahn, William C Knowler,[...]. Diabetes Care 2019
28
17







Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.